IGF-I levels reflect hypopituitarism severity in adults with pituitary dysfunction

Area of Science:

• Endocrinology
• Hormone Research
• Clinical Diagnostics

Background:

• Hypopituitarism, a condition of diminished pituitary hormone secretion, requires accurate assessment of severity.
• Insulin-like growth factor I (IGF-I) is a key indicator of growth hormone status.
• Standard deviation score (SDS) normalizes IGF-I levels for age and sex, potentially improving diagnostic utility.

Purpose of the Study:

• To determine if IGF-I standard deviation score (SDS) can serve as a surrogate marker for the severity of hypopituitarism in adults with pituitary pathology.
• To evaluate the predictive value of IGF-I SDS for various pituitary hormone deficiencies.

Main Methods:

• Retrospective analysis of 269 adult patients with pituitary disease.
• Review of complete pituitary hormone profiles and clinical data.
• Calculation of IGF-I SDS using age-adjusted reference ranges to assess correlation with pituitary hormone deficiencies.

Main Results:

• IGF-I SDS showed a significant negative correlation with the number of affected pituitary axes (p < 0.001).
• Low IGF-I SDS was predictive of gonadotropin, thyrotropin, and corticotropin deficiencies.
• Rates of diabetes insipidus correlated with IGF-I SDS values in the overall population and in patients with non-functioning pituitary adenomas.

Conclusions:

• IGF-I SDS is a valid substitute for absolute IGF-I levels in evaluating somatotroph function.
• IGF-I SDS effectively predicts the extent of hypopituitarism in adults with pituitary disease.
• IGF-I SDS can be utilized as a valuable marker for assessing hypopituitarism severity.